Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
58.29
+1.46 (2.57%)
At close: Oct 11, 2024, 4:00 PM
58.35
+0.06 (0.10%)
After-hours: Oct 11, 2024, 7:56 PM EDT
Moderna Market Cap
Moderna has a market cap or net worth of $22.41 billion as of October 11, 2024. Its market cap has decreased by -41.29% in one year.
Market Cap
22.41B
Enterprise Value
12.86B
1-Year Change
-41.29%
Ranking
Category
Stock Price
$58.29
Market Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.03B to $22.41B, an increase of 271.34%. That is a compound annual growth rate of 25.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 11, 2024 | 22.41B | -40.91% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | 41.34B | 534.20% |
| Dec 31, 2019 | 6.52B | 31.58% |
| Dec 31, 2018 | 4.95B | -17.90% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biogen | 27.18B |
| BeiGene | 25.41B |
| ICON Public Limited Company | 24.50B |
| Illumina | 22.82B |
| STERIS | 22.23B |
| The Cooper Companies | 21.13B |
| Waters | 21.02B |
| West Pharmaceutical Services | 21.02B |